Celanese Corporation (CE) | The Buildout — AI Infrastructure
The Verdict
Celanese makes engineered polymers and acetyl chemicals. The AI buildout reaches it through Engineered Materials, which sells advanced compounds into AI data-center servers: connectors, thermal management systems, wire and cable, and materials that protect chips from signal loss and heat. It is a materials-content business, not a chips or systems business — Celanese supplies the polymers inside the server, not the server itself. The Acetyl Chain, the commodity-linked intermediates business, has no AI demand linkage in the calls. The company does not size AI-only revenue.
| Market Cap | — |
| Revenue (TTM) | $9.7B |
| Revenue Growth | −2.3% |
| EBITDA Margin (TTM) | -0.5% |
| Net Debt | $11.0B |
| Earnings Beats | 4 of 7 |
| P/E (TTM) | — |
| EV/EBITDA (TTM) | — |
What We Like
- Engineered Materials adjusted EBIT is guided to grow closer to 15% than 10% in 2026 despite absorbing a $45M inventory-absorption hit, a $35M Micromax adjusted-EBIT loss, and roughly $10M of lower Ibn Sina equity earnings.
- The mix is enriching: electronics is about 10% of EM revenue but 10%–15% of its contribution margin, and medical is less than 10% of revenue but about 20% of contribution margin.
- The divestiture program is about halfway to its $1B target by end-2027 after Micromax, with at least one deal expected by end-2026, and net debt is guided from about $10B at end-2026 to about $9B at end-2027.
- Management reframed free cash flow from a one-year guide into a $700–800M 'baseline sustainable level' and laid out a leverage path from crossing 5x toward 4x and then about 3x long term.
- Cost self-help is in motion: Lanaken closure expected in Q3 2026, nylon and EM footprint savings of about $30–35M, and a newly quantified $80–100M 2027 cost-reduction program.
What We’re Watching
- Q3 2026 adjusted EPS is guided to $1.35–$1.75, lower than originally guided, on the accelerated Lanaken closure and pulled-forward EM closures.
- Working capital has slipped at every update — from a $100M source to about flat to neutral-to-slightly-positive — and was almost a $300M use year to date.
- About 14 EU ethylene damages claims are pending across Amsterdam, Munich, and Dortmund, with no dollar estimate disclosed.
- Demand stays weak at the end-use level, auto builds are down, and the Q3 margin test is whether EM price holds against raw-material flow-through.
The thesis is intact but narrow. The self-help side is delivering — pricing realized, Frankfurt restarted, Micromax closed, Lanaken accelerated — and management raised and rebranded its cash anchor. The demand side is not cooperating, and the working-capital target has slipped at every update. The open question is whether the self-help program keeps outrunning soft demand, and whether the AI data-center content ever grows into a sized revenue line or stays a narrative inside a tenth of one segment.
Earnings Beat
Celanese reported Q2 2026 revenue of $2,752M and a 22.5% gross margin. Free cash flow was $147M even as the quarter absorbed roughly $200M of working capital, taking year-to-date working-capital use to almost $300M. Engineered Materials margin expanded on pricing and mix, and the Acetyl Chain benefited from Western Hemisphere supply-disruption reliability; Acetyl Chain volumes were flat year over year.
| Metric | Q2 FY2026 | Q1 FY2026 | Q2 FY2025 | YoY |
|---|---|---|---|---|
| Revenue | $2.8B | $2.3B | $2.5B | +8.7% |
| Gross margin | 22.5% | 19.0% | 21.1% | +140bps |
| EBITDA | $315M | $397M | $426M | −26.1% |
| EPS | $1.13 | $0.40 | $1.81 | −37.5% |
| Free cash flow | $147M | $10M | $317M | -54% |
when you kind of break down an AI data center server, it's very different. The chip that's used in each of these servers is extremely expensive. And as they build these things, protecting that chip to ensure that you have protection from signal loss, that you maintain the speed that's required, that you can maintain thermal management through that system. It creates 3x the amount of opportunity for our materials in terms of connectors. It creates opportunities around the thermal management system, wire and cable applications.— Scott Richardson, CEO, 2026-08-05
Management tone: The Q2 2026 call reads resilient but cautious. Management framed the Q3 step-down as operational and timing-driven — the accelerated Lanaken closure, pulled-forward EM closures, and Ibn Sina equity timing — rather than demand-driven, and reaffirmed the full-year ~$6 adjusted EPS and $700–800M free cash flow. Compared with Q1's prudent, scenario-planning posture, the Q2 tone leaned more on self-help delivery: pricing realized, Frankfurt restarted, the divestiture target reaffirmed. Demand caution stayed explicit. Management declined to give any 2027 earnings figure.
Management Guidance
For FY2026, management reiterated adjusted EPS of roughly $6 and free cash flow of $700–800M, which it now describes as a 'baseline sustainable level.' Q3 2026 adjusted EPS is guided to $1.35–$1.75, described as a little lower than originally guided, on the accelerated Lanaken closure, pulled-forward EM closures, and about $10M of lower Ibn Sina equity earnings hitting Q3. Net debt is guided to about $10B at end-2026 and about $9B at end-2027, with leverage crossing 5x this year, a 4x next target, and a ~3x long-term frame. Working capital is expected to be neutral to slightly positive for the year. A 2027 cost-reduction program of $80–100M was newly quantified on a presentation slide.
Trajectory
The computed trajectory signals read revenue stable, with gross margin compressing 210bps, operating margin compressing 110bps, and EBITDA stable. Underneath, the two segments pull in opposite directions. Engineered Materials adjusted EBIT margin climbed from 9.6% in Q1 FY2025 to 16.6% in Q1 FY2026 on pricing, mix, and cost actions. The Acetyl Chain is deflating from its 2025 supply-disruption highs, its adjusted EBIT margin falling from 17.5% in Q2 FY2025 to 12.6% in Q1 FY2026. On the facts spine, quarterly revenue ran $2,204M in Q4 FY2025, $2,337M in Q1 FY2026, and $2,752M in Q2 FY2026.
The Model
The model's locked projections put FY+1 revenue at $9,947M and EBITDA at $2,049M, a 20.6% margin. For FY+2 it projects revenue of $10,047.5M and EBITDA of $2,075M, a 20.65% margin. That is essentially flat revenue and EBITDA across the two years, with margin holding just above 20%. The near-term anchor is self-help — cost actions, footprint closures, and pricing and mix in Engineered Materials — set against weak end demand. The FY+2 case leans on EM's higher-value pockets, including electronics, medical, and data centers, plus the $80–100M 2027 cost program landing.
| Metric | FY2025 | Next FY (E) | Following FY (E) |
|---|---|---|---|
| Revenue | $9.5B | $9.9B | $10.0B |
| YoY Growth | — | +4.2% | +1.0% |
| EBITDA | $23M | $2.0B | $2.1B |
| EBITDA Margin | 0.2% | 20.6% | 20.6% |
Projections are the median of 4 independent model runs. The model’s revenue sits 0.5% below analyst consensus.
For FY2026, management reiterated adjusted EPS of roughly $6 and free cash flow of $700–800M, which it now describes as a 'baseline sustainable level.' Q3 2026 adjusted EPS is guided to $1.35–$1.75, described as a little lower than originally guided, on the accelerated Lanaken closure, pulled-forward EM closures, and about $10M of lower Ibn Sina equity earnings hitting Q3. Net debt is guided to about $10B at end-2026 and about $9B at end-2027, with leverage crossing 5x this year, a 4x next target, and a ~3x long-term frame. Working capital is expected to be neutral to slightly positive for the year. A 2027 cost-reduction program of $80–100M was newly quantified on a presentation slide.
What Could Go Right — and Wrong
- Engineered Materials holds its margin step-up on a clean basis, with the May price increases sticking against Q3 raw-material flow-through.
- The AI data-center content converts from language into disclosed revenue as electronics contribution margin ticks up.
- Acetyl Chain Western Hemisphere margins lock in through multi-year contracts, turning a transitory supply windfall into durable EBITDA.
- The $1B divestiture target closes on schedule, accelerating net debt from about $10B toward about $9B and moving leverage toward 4x and then roughly 3x.
- The $80–100M 2027 cost program lands on a cleaner base after the accelerated Lanaken and EM footprint closures.
- Q3 2026 demand misses plan, with a soft September order book pulling segment volumes below what the cost actions assume.
- The $700–800M free cash flow baseline proves a peak rather than a floor as working capital keeps absorbing cash, stretching the deleveraging path.
- Acetyl Chain Western margins normalize faster than expected as global supply chains re-route, removing the EBITDA cushion.
- A material adverse outcome in the roughly 14 EU ethylene damage claims, which carry no disclosed dollar estimate.
- Engineered Materials price increases fail to offset raw-material flow-through in Q3, compressing margin more than guided and holding consolidated EBITDA back.
Looking Ahead
Over the next 12 months the story turns on a handful of dates. Q3 2026 earnings test the $1.35–$1.75 adjusted EPS guide, with September the critical month for Engineered Materials. Frankfurt's operating decision comes in Q3 or Q4 2026, read on demand and industry supply. At least one divestiture is expected by end-2026, part of the $1B target by end-2027. The $80–100M 2027 cost program has to land, and management has not yet framed 2027 earnings.
- Q3 2026Q3 earnings vs guide — Tests the $1.35–$1.75 adjusted EPS range and September's EM order book.
- Q3 2026Lanaken plant closure — Acetate-tow plant closes; $20–25M of annualized savings begin.
- Q3 2026Frankfurt VAE start-up — Frankfurt VAE emulsion plant expansion scheduled to start up.
- Q3/Q4 2026Frankfurt operating decision — Whether the restarted acetyl swing unit keeps running on demand.
- 2H 2026LCP compounding facility — LCP compounding facility on schedule for completion.
- End of 2026First divestiture deal — At least one deal expected.
Financials
Annual Summary
| Metric | FY2024 | FY2025 | TTM | YoY |
|---|---|---|---|---|
| Revenue | $10.3B | $9.5B | $9.7B | -7.2% |
| Gross Margin | 22.9% | 20.0% | 20.3% | 292bps |
| EBITDA | $126M | $23M | −$50M | -81.7% |
| EBITDA Margin | 1.2% | 0.2% | -0.5% | 98bps |
| Net Income | −$1.5B | −$1.2B | −$1.2B | +23.8% |
| Free Cash Flow | $531M | $803M | $708M | — |
| Net Cash | — | — | — | — |
Key Ratios (Trailing)
- P/E TTM—
- EV/EBITDA TTM—
- EV/Revenue TTM—
- Price/FCF TTM—
- Gross Margin (TTM)20.3%
- EBITDA Margin (TTM)-0.5%
- Net Margin (TTM)-12.0%
- ROIC-3.6%
- SBC / Revenue0.3%
The Company
Celanese is a global chemical and specialty-materials company with two reporting segments. Engineered Materials makes high-performance engineered polymers for high-value applications, sold under brand families including Vectra and Zenite liquid crystal polymers, Celcon and Hostaform polyoxymethylene, Celanex and Crastin thermoplastic polyesters, and Santoprene thermoplastic vulcanizates. Its primary end markets are automotive, medical, industrial, and consumer electronics. The Acetyl Chain is the integrated chain of acetyl products, acetate tow, emulsion polymers, EVA polymers, and redispersible powders, selling acetic acid, vinyl acetate monomer, acetate tow, and related products into nearly every major industrial sector.
The company is headquartered in Irving, Texas, and describes holding leading global positions on the strength of large global production capacity, operating efficiencies, proprietary technology, and competitive cost structures. Its operations include an integrated chemical plant at Clear Lake, Texas — where it runs the 50/50 Fairway Methanol joint venture with Mitsui — plus combined heat and power at Bishop, Texas, a waste-to-energy system in Nanjing, China, and solar and CO2-to-methanol projects at Clear Lake. The company is actively shrinking its footprint: it is closing the Lanaken, Belgium acetate-tow plant, exiting the Sakra, Singapore facility, and optimizing North American nylon 6,6 polymerization sites in Richmond, Virginia, and Washington, West Virginia.
Business Segments
Competitive Landscape
Celanese operates in markets the filings describe as having greater supply than demand in acetyl products and competitive pressure in engineered materials. Management says its ability to keep pace with the growth of standard-grade materials, particularly in China, will be challenged, and the company is deliberately retreating from commodity volume with a 'value over volume' strategy in Engineered Materials. In data-center materials the company points to differentiated polymer chemistries, but the source does not describe a sole-source or exclusive position there. The 10-K names more than a dozen chemical peers as litigation counterparties in EU ethylene damages claims.
- BASFNamed in the Court of Munich ethylene damages claims, according to the 10-K; also appears in the inferred wiring map as a competitor.
- DowNamed in the Munich claims and in a second claim in the Court of Dortmund; the source also lists it among natural-gas supplier relationships.
- Named in the Court of Munich ethylene damages claims, according to the 10-K.
- LyondellBasellNamed in the Amsterdam ethylene damages claims, according to the 10-K.
- Appears only in the inferred wiring map as an engineered-materials competitor; not discussed in filings.
Supply Chain
Celanese sits upstream in the materials chain, making polymers and chemicals sold into automotive, medical, electronics, and industrial products. For AI data centers it supplies compounds inside servers and their connectors and cabling — a materials supplier, not an operator or equipment maker.
Related companies
See all Chip Making companies → · How this layer works: Chapter 1, The Chip →
More on CE: Earnings recap